Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

JBT Marel (JBTM) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for JBT Marel (JBTM) over the last 17 years, with Q3 2025 value amounting to $114.9 million.

  • JBT Marel's Cash & Equivalents fell 7850.33% to $114.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $114.9 million, marking a year-over-year decrease of 7850.33%. This contributed to the annual value of $1.2 billion for FY2024, which is 15416.93% up from last year.
  • As of Q3 2025, JBT Marel's Cash & Equivalents stood at $114.9 million, which was down 7850.33% from $111.8 million recorded in Q2 2025.
  • In the past 5 years, JBT Marel's Cash & Equivalents registered a high of $1.2 billion during Q4 2024, and its lowest value of $42.8 million during Q2 2023.
  • In the last 5 years, JBT Marel's Cash & Equivalents had a median value of $101.0 million in 2025 and averaged $246.9 million.
  • As far as peak fluctuations go, JBT Marel's Cash & Equivalents skyrocketed by 100817.76% in 2024, and later crashed by 7891.44% in 2025.
  • Quarter analysis of 5 years shows JBT Marel's Cash & Equivalents stood at $78.8 million in 2021, then fell by 9.01% to $71.7 million in 2022, then surged by 574.06% to $483.3 million in 2023, then skyrocketed by 154.17% to $1.2 billion in 2024, then tumbled by 90.65% to $114.9 million in 2025.
  • Its Cash & Equivalents was $114.9 million in Q3 2025, compared to $111.8 million in Q2 2025 and $101.0 million in Q1 2025.